AbbVie invests $223m in Singapore biologics site

AbbVie invests $223m in Singapore biologics site

Source: 
Pharmaphorum
snippet: 

AbbVie has broken ground on a new $223 million expansion of its biologics manufacturing facility in Singapore, creating around 100 new jobs.